The University of Edinburgh is a core academic partner of the COG-UK consortium. The University is leading the GenOMICC study in partnership with Genomics England, Illumina and the NHS, which is analysing the whole genome sequences of approximately 20,000 people who have been severely affected by COVID-19. The genomes will be analysed with the aim of understanding how a person’s genetics may influence their susceptibility to the virus. This data, from the person’s own genome, will be linked to the virus genome data provided via COG-UK.
Contributors:
- Professor Andrew Rambaut, Professor of Molecular Evolution
- Dr Samantha Lycett, Group Leader
- Dr Benjamin Jackson, Research Fellow
- Rachel Colquhoun, Postdoctoral Researcher
- JT McCrone, Postdoctoral Researcher
- Emily Scher, Postdoctoral Research Associate
- Nathan Medd, Training and Outreach Manager, Edinburgh Genomics
- Verity Hill, PhD student
- Áine O’Toole, PhD student
- Stefan Rooke, PhD student
- Dr Kate Templeton, Consultant Clinical Scientist, RIE and Honorary Senior Lecturer in Medical Microbiology
- Dr Thomas Williams, Institute of Genetics and Molecular Medicine
- Dr Carlos Balcazar [LinkedIn]
- Dr Kathleen Williamson, Research Fellow, Deanery of Molecular, Genetic and Population Health Sciences, MRC Human Genetics Unit [ORCID]
- Dr Daniel Maloney, Post Doctoral Researcher
- Dr Martin McHugh, Clinical Scientist in Medical Microbiology, NHS Lothian
- Dr Rebecca Dewar, Pre-registration Clinical Scientist, NHS Lothian
